Cisatracurium

Sold as Nimbex ( ), Nimbex, Cisatracurium mylan ( ), Cisatracurium safeline, Cistrax, Cisaject

No structure available

This product's active ingredient could not be matched to a single known compound.

Loading Wikipedia summary

Registration

Applicants: 5
Registrations: 15
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Pharmacare limited û woodmeadCertificate held by Aspen pharmacare	Nimbex ( ), Nimbex	2mg/ml 2,5 ml, 2mg/ ml 5,0 ml, 2mg/ml 10 ml, 5	310255, 310256, 310444, 310445	S4	PI PIL
Viatris Healthcare (Pty) Ltd	Cisatracurium mylan ( )	2 mg/ml 2,5 ml, 2 mg/ml 5 ml, 2 mg/ml 10 ml, 5 mg/ml 30 ml	480686, 480687, 480688, 480689	S4	None
Safeline Pharmaceuticals (Pty) Ltd	Cisatracurium safeline	5 mg, 10 mg, 20 mg	490101, 490102, 490103	S4	None
Accord Healthcare (Pty) Ltd	Cistrax	5mg/ 2.5ml, 10mg/ 5ml, 150mg/30ml	500131, 500132, 500133	S4	None
Lamar International (Pty) Ltd	Cisaject	Not stated	511028	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Nimbex 2mg/ml (2,5 ml) EACH 1 ml SOLUTION CONTAINS CISATRACURIUM BESYLATE EQUIVALENT TO 2 mg CISATRACURIUM	2mg/ml 2,5 ml	31025531/17.1//0255	Registered	S4	None
Nimbex 5 EACH 1 ml SOLUTION CONTAINS CISATRACURIUM BESYLATE EQUIVALENT TO 5 mg CISATRACURIUM	5Injection	31025631/17.1/0256Approved 24 February 2023	Registered	S4	PI PIL
Nimbex 2mg/ ML (5,0 ml) EACH 1 ml SOLUTION CONTAINS CISATRACURIUM BESYLATE EQUIVALENT TO 2 mg CISATRACURIUM	2mg/ ml 5,0 ml	31044431/17.1/0444	Registered	S4	None
Nimbex 2mg/ml (10 ml) EACH 1 ml SOLUTION CONTAINS CISATRACURIUM BESYLATE EQUIVALENT TO 2 mg CISATRACURIUM	2mg/ml 10 ml	31044531/17.1/0445	Registered	S4	None
Cisatracurium mylan 2 mg/ml (2,5 ml) EACH 1,0 ml SOLUTION CONTAINS CISATRACURIUM BESYLATE EQUIVALENT TO CISATRACURIUM 2,0 mg	2 mg/ml 2,5 ml	48068648/17.1/0686	Registered	S4	None
Cisatracurium mylan 2 mg/ml (5 ml) EACH 1,0 ml SOLUTION CONTAINS CISATRACURIUM BESYLATE EQUIVALENT TO CISATRACURIUM 2,0 mg	2 mg/ml 5 ml	48068748/17.1/0687	Registered	S4	None
Cisatracurium mylan 2 mg/ml (10 ml) EACH 1,0 ml SOLUTION CONTAINS CISATRACURIUM BESYLATE EQUIVALENT TO CISATRACURIUM 2,0 mg	2 mg/ml 10 ml	48068848/17.1/0688	Registered	S4	None
Cisatracurium mylan 5 mg/ml (30 ml) EACH 1,0 ml SOLUTION CONTAINS CISATRACURIUM BESYLATE EQUIVALENT TO CISATRACURIUM 5,0 mg	5 mg/ml 30 ml	48068948/17.1/0689	Registered	S4	None
Cisatracurium safeline 5 MG EACH AMPOULE CONTAINS : CISATRACURIUM BESILATE EQUIVALENT TO CISATRACURIUM 5,0 mg	5 mg	49010149/17.1/0101	Registered	S4	None
Cisatracurium safeline 10 MG EACH AMPOULE CONTAINS : CISATRACURIUM BESILATE EQUIVALENT TO CISATRACURIUM 10,0 mg	10 mg	49010249/17.1/0102	Registered	S4	None
Cisatracurium safeline 20 MG EACH AMPOULE CONTAINS : CISATRACURIUM BESILATE EQUIVALENT TO CISATRACURIUM 20,0 mg	20 mg	49010349/17.1/0103	Registered	S4	None
Cistrax 5mg/ 2.5ml EACH VIAL CONTAINS: CISATRACURIUM BESYLATE EQUIVALENT TO CISATRACURIUM 5,0 mg	5mg/ 2.5ml	50013150/17.1/0131	Registered	S4	None
Cistrax 10mg/ 5ml EACH VIAL CONTAINS: CISATRACURIUM BESYLATE EQUIVALENT TO CISATRACURIUM 10,0 mg	10mg/ 5ml	50013250/17.1/0132	Registered	S4	None
Cistrax 150mg/30ml EACH VIAL CONTAINS CISATRACURIUM BESYLATE EQUIVALENT TO CISATRACURIUM 150,0 mg	150mg/30ml	50013350/17.1/0133	Registered	S4	None
Cisaject EACH VIAL CONTAINS: CISATRACURIUM BESILATE EQUIVALENT TO CISATRACURIUM 10,0 mg	Not listed	51102851/17.1/1028	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Cisatracurium besylate equivalent to cisatracurium

S4: Cisatracurium
Consolidated Schedules 06 July 2026, line 5819

Pharmacological class: Peripherally acting muscle relaxants. (class 17.1)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Nimbex 5, Pharmacare limited û woodmead is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsNimbex 5, Pharmacare limited û woodmead Patient information leaflet (PIL)For patients and carersNimbex 5, Pharmacare limited û woodmead

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background